-
Sector Analysis
Age-Related Macular Degeneration: Global Drug Forecast and Market Analysis to 2026
There are two clinical forms of age-related macular degeneration (AMD): dry and wet. Currently there are therapies available only for wet AMD. Drugs in late stages of development target the wet AMD segment and the late stage or atrophic form of dry AMD, called geographic atrophy (GA). The global markets are currently overwhelmingly dominated by anti-VEGFs for wAMD, including Lucentis, Eylea, and Avastin, which together accounted for 99.3% of AMD sales. Visudyne, photodynamic therapy (PDT), is used in a minority...
-
Sector Analysis
PharmaPoint: Age-Related Macular Degeneration – Global Drug Forecast and Market Analysis to 2026
There are two clinical forms of age-related macular degeneration (AMD): dry and wet. Currently there are therapies available only for wet AMD. Drugs in late stages of development target the wet AMD segment and the late stage or atrophic form of dry AMD, called geographic atrophy (GA). The global markets are currently overwhelmingly dominated by anti-VEGFs for wAMD, including Lucentis, Eylea, and Avastin, which together accounted for 99.3% of AMD sales. Visudyne, photodynamic therapy (PDT), is used in a minority...
-
Sector Analysis
Dry Eye Syndrome Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2018-2028
Dry Eye Syndrome Market Report Overview The Dry Eye Syndrome (DES) market size across the 7MM was valued at $3.4 billion in 2018 and is forecast to grow at a CAGR of more than 11% during 2018-2028. The Dry Eye Syndrome market research report provides an overview of DES, including epidemiology, pathophysiology, diagnosis, and disease management. Dry Eye Syndrome Market Outlook To gain more information on the dry eye syndrome market forecast, download a free report sample
-
Sector Analysis
Retinitis Pigmentosa - Opportunity Assessment and Forecast
Retinitis pigmentosa (RP) is an inherited retinal dystrophy that is caused by mutations in genes that code for proteins involved in maintenance and function of the photoreceptor cells, cones and rods. While RP genotypes are heterogenous, it is also important to note that patients with the same mutation can exhibit different phenotypic manifestations. The genetic mutations can cause a number of effects including an inability to produce the required protein, the production of a toxic protein, or the formation of...
-
Sector Analysis
Dry Eye Syndrome: Global Drug Forecast and Market Analysis to 2026
Dry Eye Syndrome (DES) is a multifactorial disease of the tears and ocular surface that causes ocular discomfort, visual disturbances, and tear film instability, which can potentially damage the ocular surface. With a rapidly accelerating worldwide prevalence and the limited treatment options available, there is a growing pressure for new therapies and curative treatment for DES patients. Significant efforts are being made to develop a new treatment for DES, as current pharmacologic management is known to only provide temporary symptomatic...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.